Andrew Booth

Andrew Booth

Chief Financial OfficeratAbCellera Biologics· In proxies 2021–2025

Pay in FY2025-1% from the year before · AbCellera Biologics stock +16.7% the same year

Andrew Booth was paid $3.4M in FY2025 (Dec), down 1%. AbCellera Biologics stock rose 16.7% that year.

Pay$100 in the stock at the end of FY20 → $8
Pay is from the Summary Compensation Table of each AbCellera Biologics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. AbCellera BiologicsPublic company · 5 yr
    • Chief Financial Officer2021 – Present · 5 yrStock in role -68%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?